Actively Recruiting
Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine
Led by Rhode Island Hospital · Updated on 2026-03-25
120
Participants Needed
1
Research Sites
71 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators are evaluating postoperative outcomes in patients undergoing hip replacement surgery performed with either spinal or general anesthesia, who also receive a suprainguinal fascia iliaca block using either perineural ropivacaine alone or ropivacaine combined with dexmedetomidine.
CONDITIONS
Official Title
Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing elective total hip arthroplasty
- Age between 18 and 80 years
- ASA physical status classification of 1 to 3
You will not qualify if you...
- ASA physical status classification of 4 or higher
- Infection at the site of nerve blockade
- Coagulopathy
- Known allergy to study medications
- Chronic opioid use for more than 3 months
- Current use of lidocaine patches
- Pre-existing neuropathy
- History of cerebrovascular accident (CVA)
- High-grade atrioventricular block
- Organ dysfunction including cardiac failure, respiratory failure, end stage renal disease, hepatic dysfunction, or hypoalbuminemia
- Morbid obesity (body mass index ≥40 kg/m2)
- Prior surgery in suprainguinal or infrainguinal region
- Non-English-speaking participants
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Miriam Hospital
Providence, Rhode Island, United States, 02906
Actively Recruiting
Research Team
V
Vendhan Ramanujam, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here